(ChIP-chip or ChIP-Seq) or reverse engineering algorithms for the analysis of transcriptional networks 4, 10 , only one experimentally validated algorithm exists for the dissection of signaling networks in a mammalian context 11 , which inferred substrates of 73 kinases. Here we propose and experimentally validate MINDy, a gene expression profile method for the systematic identification of genes that modulate the transcriptional program of a transcription factor at the post-translational level-that is, genes encoding proteins that affect the TF's activity without changing the abundance of its mRNA. These proteins may post-translationally modify the TF (for example, kinases), affect its cellular localization or turnover, be its cognate partners in transcriptional complexes or compete for its DNA binding sites. They may also include proteins that do not physically interact with the TF, such as those in its upstream signaling pathways.
RESULTS

The MINDy algorithm
MINDy interrogates a large gene expression profile dataset to identify 'candidate modulator' genes whose expression strongly correlates with changes in a TF's transcriptional activity. As shown in Supplementary Note 1 (see also Supplementary Figs. 1-3 ), this can be efficiently accomplished by computing an information-theoretic measure known as the conditional mutual information, I[TF;t | M] 12 , between the expression profile of a TF and one of its putative targets (t), given the expression of a modulator gene (M). Accurate estimation of the conditional mutual information requires exceedingly large datasets. Thus MINDy infers candidate modulators using a related yet simpler estimator, which we denote as ∆I. Briefly, the estimator assesses the statistical significance of the difference in mutual information between the TF and a target in two subsets-the top and bottom 35% of samples in which the modulator is most and least expressed. The 35% parameter was determined empirically as the one optimizing the identification of proteins in the B-cell receptor signaling pathway as modulators of MYC (Online Methods).
A schematic representation of the MINDy algorithm is provided in Figure 1a . MINDy takes four inputs: a gene expression profile dataset, a TF of interest, a list of potential modulator genes (M 1 , M 2 ,...) and a list of potential TF targets (t 1 , t 2 ,...). The ∆I estimator requires that the expression of the modulator and of the TF be statistically independent ('independence constraint') and that the modulator expression have sufficient range ('range constraint'). Appropriate statistical tests for these
The ability of a transcription factor (TF) to regulate its targets is modulated by a variety of genetic and epigenetic mechanisms, resulting in highly context-dependent regulatory networks. However, high-throughput methods for the identification of proteins that affect TF activity are still largely unavailable. Here we introduce an algorithm, modulator inference by network dynamics (MINDy), for the genome-wide identification of posttranslational modulators of TF activity within a specific cellular context. When used to dissect the regulation of MYC activity in human B lymphocytes, the approach inferred novel modulators of MYC function, which act by distinct mechanisms, including protein turnover, transcription complex formation and selective enzyme recruitment. MINDy is generally applicable to study the post-translational modulation of mammalian TFs in any cellular context. As such it can be used to dissect context-specific signaling pathways and combinatorial transcriptional regulation.
Reverse engineering of cellular networks in prokaryotes and lower eukaryotes [1] [2] [3] , as well as in mammals [4] [5] [6] , has started to unravel the remarkable complexity of transcriptional programs. These programs, however, may change substantially as a function of the availability of proteins affecting their post-translational modification of transcription factors, such as phosphorylation, acetylation and ubiquitination enzymes 7 , as well as of those participating in transcription complexes (cofactors), thus making cellular networks highly context dependent.
Although the large-scale reprogramming of the cell's transcriptional logic has been studied in yeast 8, 9 , the identification of genes that affect these events remains elusive. Indeed, in contrast to methods such as those based on genome-wide chromatin immunoprecipitation Genome-wide identification of post-translational modulators of transcription factor activity in human B cells when the TF is slightly activated. In that case, TF-target mutual information will actually decrease as a function of the modulator. Details on the conditional mutual information analysis and on how to assess both the mode of action and the biological activity of a modulator are provided in the Online Methods.
For illustrative purposes, we show a simple synthetic network ( Fig.  1b ; Online Methods), which explicitly models two post-translational modulation events (activation by phosphorylation and cofactor binding) differentially affecting a TF's regulatory logic. Rather than representing a realistic case, this model is only a conceptual tool to illustrate two alternative regulatory programs of a TF depending on its modulators (Fig. 1c) .
constraints are discussed in the Online Methods. Candidate modulators may include all genes satisfying these constraints (unbiased analysis) or may be filtered by additional criteria-for example, their molecular functions. Each possible (TF, M, t) triplet is then independently tested using the ∆I estimator. False positives are controlled using appropriate statistical thresholds (Online Methods).
A positive or negative mode of action is determined, depending on whether the TF-target mutual information increases or decreases as a function of the modulator abundance (Fig. 1a) . The mode of action, however, is not necessarily equivalent to the modulator's biological activity as a TF activator or antagonist. For instance, a modulator may be such a strong TF activator that the TF-target kinetics becomes saturated even Given a transcription factor of interest (TF), a modulator (M) and a target (t) to be tested are chosen among the remaining genes. Some modulator-target combinations may be eliminated a priori based on functional or statistical constraints (blue rectangle). For instance, one may want to consider only ubiquitin ligases as candidate modulators. All the samples are then sorted according to the expression of the selected modulator M. The set of samples (for example, 35%) with the lowest and highest expression of the modulator are then selected. These sample sets are labeled M low and M high. In each of the two sample sets, samples are finally sorted according to the TF expression. Three cases are possible when comparing the TF-target correlation in M high versus M low. In Scenario 1 (positive inferred modulator), there is a significant increase in mutual information (that is, more correlation in the M-high set than in the M-low set). In Scenario 2 (negative inferred modulator), there is a significant decrease in mutual information (that is, less correlation in the M-high set than in the M-low set). In Scenarios 3 and 4 (not a modulator), no significant mutual information change is observed. 
A N A LY S I S
To study MINDy's robustness and generality, we tested its performance using different sets of candidate MYC targets. First, we used 340 literature-validated targets from the MYC database 19 (DB targets). Then, to also test whether the algorithm may generalize to TFs whose targets are not characterized in the literature, we used 197 MYC targets inferred by ARACNe 4 , our previously described method for inferring the direct targets of a TF (AR targets). Finally, we considered all genes in the gene expression profile data as candidate targets (ALL targets), representing cases when literature or computationally inferred TF targets are not available (Supplementary Note 2).
MINDy-based identification of MYC modulators
We applied MINDy to the genome-wide identification of modulators of the MYC protein, using a previously assembled collection of 254 gene expression profiles 13, 14 representing 17 distinct cellular phenotypes derived from normal and neoplastic human B lymphocytes (Online Methods). MYC is a basic helix-loop-helix/leucine zipper (bHLH/Zip) TF controlling many cellular processes, including cell growth, differentiation, apoptosis and DNA replication 15, 16 . It is implicated in the pathogenesis of several human cancers 17 and can either activate or repress a large number of targets, depending on the cellular context (reviewed in ref. 18 ). A N A LY S I S likely to affect MYC protein function, although there may be false positives. Though not exhaustive, this provides an independently established literature-based dataset to assess algorithm performance (see Supplementary Note 3 for details on inclusion criteria). From this set, 150 genes were excluded as not represented on the chip, not expressed in B cells or not satisfying the range or independence constraints. Of the remaining 83, 29 (35%) were inferred as MYC modulators by the algorithm (P = 0.0078 by FET). This suggests that the algorithm is effective in recapitulating known MYC modulators (especially as Ingenuity modulators may not be B-cell specific) with recall comparable to that of high-throughput assays for protein-protein interactions, which on average detect 20% of known interactions 23 . We note that 54/83 proteins were reported by Ingenuity as MYC modulators not supported by a direct physical interaction. Of these, MINDy identified 18 (33.3%, P = 0.041 by FET), suggesting that MINDy is useful in identifying both physically interacting and indirect TF-modulators and
MINDy identifies known MYC modulators
From a pool of 3,131 genes satisfying both independence and range constraints and using DB targets, MINDy inferred 662 MYC modulators (Supplementary Table 1 ) at a false-discovery rate (FDR) of 4.5 × 10 −3 (Online Methods). Gene Ontology (GO) "molecular function" enrichment analysis revealed that the 20 most enriched categories, by Fisher's exact test (FET), include protein kinase activity (P = 0.002), TF binding (P = 0.003), acetyltransferase activity (P = 0.004) and phosphoprotein phosphatase activity (P = 0.016). Thus, inferred modulators were enriched in categories known to include effectors of MYC activity [20] [21] [22] (Online Methods and Supplementary Table 2) .
To test whether MINDy could recapitulate literature-based MYC modulators, we assembled an unbiased set of 233 MYC modulators, including both proteins physically interacting with MYC and indirect modulators (Supplementary Table 3 ), using the Ingenuity software (Ingenuity Systems). The assumption is that physical interactors are A N A LY S I S (Fig. 2b) , suggestive of a post-translational modulation effect. We proceeded to test two MYC targets in MINDy predictions, BCL2 and NME1, which are normally repressed by MYC 26, 27 . Consistently with what MINDy predicted, both genes were upregulated after STK38 that methods relying only on known molecular interactions would miss the vast majority of TF modulators. Indeed, based on Ingenuity almost twice as many modulators (18 versus 11) were found by MINDy among proteins not known to interact directly with MYC, compared to those having a physical protein-protein interaction.
To focus our analysis on specific molecular functions, we restricted candidate modulators to 542 signaling proteins-including protein kinases, phosphatases, acetyltransferases and deacetylases-and to 598 TFs (Online Methods). Among these, MINDy identified 91 signaling proteins (Supplementary Table 4 ) and 99 TFs (Supplementary Table 5) , respectively, as MYC modulators (FDR = 0.0053). For each modulator, virtually all of the ∆I tests inferred the same mode of action (see columns "T+" and "T-" in Supplementary Tables 4 and 5) and fewer than 15% of the modulators had an ambiguous biological activity.
To assess a lower bound on the fraction of true positives among inferred modulators (that is, the precision), we performed manual literature curation. Because of the labor-intensive nature of this step, we considered only 29 signaling proteins and 35 TFs affecting more than 30 MYC targets. Among the former ( 24 , we tested whether their binding sites were enriched in promoters of the modulated targets (Online Methods). Fourteen of 35 TFs had appropriate binding profiles, and of these, 11 were highly enriched. Overall, 17 of 35 TFs (precision = 48.6%) either were literature-validated or had enriched binding sites (see Table 1 and Supplementary Table 6 ). This suggests that MINDy's precision may approach that of experimental assays 23 when all modulators will be experimentally tested.
We then compared the performance of MINDy using literature-based targets (DB targets) to that with targets computationally inferred by ARACNe (AR targets). Overlap between the two target sets was highly significant (P = 2.89 × 10 −18 ) but relatively small (17%). Nonetheless, overlap between MINDy-inferred modulators, when using the two target sets, was almost complete: 93.8% (P = 3.10 × 10 −27 ) among signaling proteins and 95.3% (P = 4.56 × 10 −288 ) among TFs, respectively (Supplementary Note 2 and Supplementary Tables 7 and 8) . This suggests that the method is highly robust with respect to target selection and can be effectively generalized to TFs whose targets are not known from the literature but can be inferred computationally.
Experimental validation
We selected four candidates among signaling genes and co-TFs for experimental validation, including a kinase (STK38), two TFs (BHLHB2 and MEF2B) and a deacetylating enzyme (HDAC1). These genes were selected based on the availability of reagents allowing the thorough validation of their activity and on the diversity of the possible mechanisms by which they may modulate MYC activity. As no single B-cell line expressed more than two of the four tested modulators, appropriate lines were selected for the silencing experiments among those with the highest modulator expression.
STK38 mediates MYC phosphorylation and protein stability
As a first candidate, we validated STK38, a serine/threonine kinase 25 inferred by MINDy as a strong positive modulator of MYC activity, affecting 60 targets (Fig. 2a, Supplementary Table 4) . We silenced STK38 by lentiviral vector-mediated short hairpin RNA (shRNA) expression in ST486 cells. Although quantitative reverse transcription PCR (qRT-PCR) analysis showed that MYC mRNA concentration was unchanged after STK38 silencing, MYC protein levels were significantly affected A N A LY S I S silencing, while the third one, p21 CIP1 , which is known to be repressed by MYC 29 , was upregulated (Fig. 2c) . These results confirm the observed target-independent downregulation of MYC at the protein level. Furthermore, STK38-mediated modulation of MYC affected its phosphorylation. Immunoblot analysis of MYC protein in ST486 cells, in the presence of an inhibitor of proteasomal degradation (MG132), showed accumulation of phosphorylated MYC in cells following STK38 silencing compared to cells treated with control shRNA, suggesting that STK38 mediates MYC phosphorylation (Fig. 2d) .
Finally, coimmunoprecipitation (co-IP) of epitope-tagged STK38 (hemagglutinin (HA)-STK38) and MYC (FLAG-MYC), in 293T cells transfected with vectors expressing both proteins, showed that STK38 and MYC interacts at the protein level (Fig. 2e) . Immunoprecipitation of endogenous MYC using specific antibodies in Ramos cells confirmed that the two proteins can interact physiologically in native cells (Fig. 2f) . These results suggest that STK38 modulates MYC activity by directly affecting MYC protein stability.
BHLHB2 is a MYC antagonist
MINDy infers this TF as a negative modulator of MYC activity, affecting the regulation of 80 targets (Fig. 3a, Supplementary Table 5 ). Indeed, BHLHB2 is a TF able to bind to E-boxes through its bHLH domain, and it has been proposed to act as a transcriptional repressor 30 , but it has not been validated as a MYC antagonist. Thus, we tested whether BHLHB2 could antagonize MYC-mediated transcriptional activation of its target genes by first investigating whether BHLHB2 could affect the transcriptional activation of TERT, a well-characterized MYC target 28 .
Transient co-transfection in 293T cells of a reporter gene driven by a segment of the human TERT promoter region, carrying two E-boxes (TERT-Luc800 28 ), and vectors encoding MYC or BHLHB2 showed that BHLHB2 represses MYC-mediated transcriptional activation on TERT in a dose-dependent manner. This effect is MYC dependent, as the basal transcriptional activity of the reporter gene is actually moderately increased by BHLHB2 (1.2-fold, Fig. 3b) . Thus BHLHB2 represses MYC-mediated regulation but is not a direct repressor of the TERT promoter.
We next analyzed whether endogenous BHLHB2 molecules are physiologically bound to E-boxes within the promoter region of MYC target genes in vivo by quantitative chromatin immunoprecipitation (qChIP) assays in B-cells (ODH-III) using antibodies against MYC and BHLHB2. The results showed that the promoters of BOP1, ATIC, MRPL12, EBNA1BP2 and TERT were bound by both MYC and BHLHB2 (Fig. 3c) .
To establish the functional significance of BHLHB2-mediated modulation of MYC transcriptional activity, we examined whether shRNAmediated inhibition of BHLHB2 could affect the response of the 340 canonical MYC target genes used in the MINDy analysis or, more specifically, of the MYC target genes modulated by BHLHB2 as inferred by MINDy. The latter signature was used in case the effect was highly target specific and thus only a subset of MYC targets might be affected by BHLHB2 silencing. To this end, ODH-III cells were transduced with lentiviral vectors expressing BHLHB2-specific or control shRNAs. Western blot analysis showed that BHLHB2 was effectively silenced, while MYC levels were not affected (Supplementary Fig. 4) .
We then performed gene expression profile analysis to assess the effect of BHLHB2 silencing on the expression of MYC targets. MYC is known to both positively and negatively regulate its targets 31 . Thus, without prior knowledge of MYC's specific activity on each target, we used gene set enrichment analysis (GSEA) 32 to assess whether MYC target signature genes are more differentially expressed than non-MYC target genes following BHLHB2 silencing (Online Methods). The analysis confirmed a silencing (Fig. 2c) . Additionally, to test whether STK38-mediated MYC modulation is target specific, we tested three additional MYC targets not inferred by MINDy. The first two, TERT and EBNA1BP2, which are known to be activated by MYC 4, 28 , were downregulated following STK38 A N A LY S I S that HDAC1 may modulate MYC activity both by deacetylation of the MYC protein and by transcriptional repression of selected targets.
Extension to other TFs
To validate MINDy on a broader range of TFs, we used the algorithm to infer all TFs modulated by BHLHB2, MEF2B, HDAC1 and STK38, for highly significant enrichment of canonical MYC targets within the differentially expressed genes (P < 0.001) (Fig. 3d) . Among the 80 MINDy inferred BHLHB2-modulated MYC targets, 30 were among the most differentially expressed genes. This constitutes approximately a twofold increase over their enrichment in non-differentially expressed genes (P = 8 × 10 -5 by FET). MYC mRNA and protein levels were not affected (data not shown and Supplementary Fig. 4) , indicating a post-translational effect. These results validate BHLHB2 as an antagonist of MYC activity.
MEF2B is a positive modulator of MYC activity
This TF was inferred as a positive modulator of MYC activity, affecting 14 MYC targets (Fig.  4a, Supplementary Table 5 ). MEF2B is a member of the MEF TF family, which interacts with the myogenic bHLH proteins MyoD and E12 to activate gene transcription through direct binding to E-boxes on target promoters 33 . Details of the validation assays are provided in Supplementary Note 4.
Briefly, similar to our observations with BHLHB2, we showed that (i) MEF2B physically interacts with MYC both exogenously in 293T cells (Fig. 4b) and endogenously in P3HR1 and Ramos cells (Fig. 4c); (ii) MYC and MEF2B can synergistically activate a TERT reporter gene (Fig. 4d) ; and (iii) genes differentially expressed following shRNA-mediated silencing of MEF2B were highly enriched in MYC targets by GSEA (P < 0.001, Fig. 4e ), whereas MYC expression was not affected (Supplementary Fig. 5b ).
HDAC1 may deacetylate MYC and repress MYC targets
Finally, MINDy identified the histone deacetylase and well-known transcriptional co-repressor HDAC1 (refs. 34,35) as a modulator of MYC transcriptional activity on eight MYC targets (Fig. 5a, Supplementary Table 4) . Experiments (see Supplementary Note 5 for details) confirmed that (i) HDAC1 and MYC can interact in vivo, both exogenously in 293T cells (Fig. 5b) as also reported in ref. 36 and endogenously in Ramos and P3HR1 cells (Fig. 5c); (ii) genes differentially expressed following shRNAmediated silencing of HDAC1 were highly enriched in MYC targets by GSEA (P < 0.001, Fig. 5d ), whereas MYC expression was not affected ( Supplementary Fig. 6a) ; (iii) HDAC1 can deacetylate MYC in vitro, following its CBPmediated acetylation (Fig. 5e) , which has been shown to increase MYC's activity as a transcriptional activator; and (iv) as indicated by qChIP assays with anti-MYC and anti-HDAC1 specific antibodies, both MYC and HDAC1 bind to the promoters of p21 CIP1 and CR2, which are repressed by MYC in B-cells (Fig. 5f) .
These results suggest that MYC may recruit HDAC1 to repress transcription of specific target genes. Taken together, our data demonstrate 
A N A LY S I S
not yet been extended to mammalian networks. Finally, comparison with a recently introduced algorithm, NetworKIN 11 , shows that the latter is restricted to substrates of only 73 kinases, from 20 families, whereas MINDy can be used to dissect post-translational interactions of a much wider nature, including phosphorylation, acetylation, chromatin modification, formation of transcription complexes and binding-site antagonism, as we have demonstrated here for STK38, HDAC1, MEF2B and BHLHB2. The ability to infer direct and upstream modulators of a desired TF's activity suggests that MINDy may provide highly specific pharmacological targets for the activation or repression of specific transcriptional programs, when modulators are restricted to druggable genes 40 . This could be valuable because TFs are generally considered difficult pharmacological targets.
Although preliminarily applied to identifying modulators of MYC for experimental validation purposes, MINDy has already provided biological insights. First, the results indicate that not all modulators can influence the program of a TF in a global fashion; they may rather influence specific subsets of the target genes. This observation suggests that additional levels of regulation can influence the relationships between modulators and the TFs they control in different cellular contexts or depending on different signals. Second, MINDy identified novel molecules that regulate the activity of the MYC protein. These mechanisms may be critically altered in tumors, thus modulating MYC's established oncogenic activity. Finally, MINDy is not limited to dissecting posttranslational interactions and may be applied without modification to identify TFs that are directly modulated by microRNAs or indirectly by genetic and epigenetic alterations.
Algorithm availability. At manuscript publication, the source code and executables for MINDy will be made available under the Open Source licensing agreement. Additionally, MINDy will be incorporated into the geWorkbench package, which is distributed both by the US National Cancer Institute and by the National Center for Biomedical Computing at Columbia University (http://wiki.c2b2.columbia.edu/ workbench/index.php/Home). which we had already collected gene expression profile data following shRNA-mediated silencing (Supplementary Note 6) . Specifically, we tested (by GSEA) whether their MINDy-inferred targets were enriched in differentially expressed genes following lentivirus-mediated shRNA silencing of the corresponding modulators. Seventy-five percent of the TFs inferred by MINDy as modulated by any of the four modulators with support from more than 100 targets, could be experimentally validated by the analysis (33 out of 44, P ≤ 5.1 × 10 −34 ) (Supplementary Table 9) . Furthermore, as one may expect, validation rates increased-from 51% (87 out of 171) to 61% (59 out of 96) to 75% (33 out of 44)-when the minimum number of MINDy-inferred targets supporting the modulator was increased from 25 to 50 to 100, respectively. In general, these results are consistent with the MYC analysis and suggest that MINDy is broadly applicable to the analysis of TFs other than MYC.
DISCUSSION
We have introduced MINDy, a new method for the identification of context-specific, post-translational modulators of TF activity. Literature-based and experimental validation suggests that MINDy can recapitulate a large fraction of known MYC modulators and infer novel, context-specific modulators of both MYC and other TFs.
For well-studied TFs, targets for the analysis may be selected from the literature or by performing genome-wide ChIP assays 37, 38 . However, computationally inferred targets performed as well as or better than literature-based ones, likely due to their context-specific nature. About 269 TFs have more than 50 ARACNe-inferred targets using the B-cell profiles and may thus be effectively analyzed by MINDy.
Algorithm performance was remarkably robust to candidate target selection (DB targets versus AR targets). Additionally, the input data required by MINDy is relatively straightforward, requiring only the availability of a large gene expression profile dataset (n ≥ 200 profiles) characterizing a sufficient variety of naturally occurring or experimentally perturbed cellular phenotypes. This suggests that MINDy can be used to analyze most TFs in a variety of cellular contexts.
Several limitations should be noted. First, candidate modulators that do not satisfy the range constraint cannot be tested by the method. These, however, primarily include either genes that are not expressed or genes whose availability is so tightly regulated (for example, housekeeping genes) that variability in the gene expression profiles is too limited to establish a low and a high range of expression. Second, candidate modulators that do not satisfy the independence constraint may not be tested using this approach. In practice, fewer than half (100/233 = 42.9%) of the Ingenuity modulators were in this category. This is not a theoretical limitation of the method but rather an assumption we use to increase its sensitivity; thus, if desired, a more general test may be used without relying on the assumption I[TF; M] = 0 (Supplementary Note  1) . Additionally, transcriptional modulators of MYC can be directly inferred by ARACNe and do not require MINDy. Third, in the rare event that the regulatory program of a TF changes from activation to repression for specific targets, as a function of a modulator, this may not be detected by the algorithm because the mutual information may not change substantially. In this case the multi-information could be used instead of the conditional (Supplementary Note 1) .
MINDy is able to discover large numbers of modulators of the same TF. In contrast, finding the optimal Bayesian network structure, assuming arbitrary interactions among TF modulators (that is, the TF parents in the network topology), would have time and memory requirements that are hyperexponential in the number of modulators. As a result, dissecting network topologies with large numbers (tens to hundreds) of upstream modulators, such as those of MYC, may be difficult. Other methods 39 , although promising in a yeast context, have A N A LY S I S > 0 (∆I < 0). This indicates only whether M increases or decreases the mutual information between TF and t, and does not necessarily correspond to the biological activity of the modulator (the TF activator or repressor). The latter can be assessed for each tested triplet as:
where ρ is the Pearson correlation between the TF and the candidate target t, and ± is the mean expression of t in L m ± . We assess these differences using a twosample Student's t-test with 10% type-I error rate (two sided). For modulators affecting more than one MYC target, the biological mode is labeled as undetermined if the undetermined triplets are the majority (>50%) or if neither mode dominates the other by more than 30%. Otherwise it is assigned the dominant mode (Supplementary Note 13 and Supplementary Table 12) . GO enrichment analysis. GO molecular function categories with fewer than 20 and more than 500 genes were excluded. The enrichment of each category was computed using the Fisher's exact test and corrected for multiple testing using the method of Storey and Tibshirani 43 .
Promoter analysis. For TFs with an appropriate DNA binding profile in the TRANSFAC professional database (version 6.0) 24 , we determined the bindingsite enrichment in the promoter regions (defined as 2 kb upstream and 2 kb downstream of the transcription initiation site, masked for repetitive elements) of the targets they modulate. Sequences were retrieved from the UCSC Golden Path database (build 35, May 2004) 44 . The binding profile match threshold was calibrated for a FDR of ≤5% per 1 Kb (in both directions). The binding-site enrichment, compared to a 13,000 random human promoter 5 background, was computed by Fisher's exact test.
Cell lines and cell culture. The human embryonic kidney 293T cells were maintained in DMEM supplemented with 10% FBS and antibiotics. The Burkitt lymphoma cell lines, Ramos, P3HR1, ST486 and ODH-III, were maintained in IMDM supplemented with 10% FBS and antibiotics.
Plasmids. The mammalian expression vectors encoding MYC and TERT-800Luc have been previously described 28 . The mammalian expression vectors encoding BHLHB2/Stra13-FLAG, HDAC1-FLAG and HA-MEF2B were kindly provided by R. Taneja (Mount Sinai School of Medicine, New York), S.L. Schreiber (Harvard University, Cambridge, Massachusetts) and R. Prywes (Columbia University, New York), respectively. HA-STK38 (pcDNA3.1-NDR1-wt) expression vector was provided by B. Hemmings (FMI, Basel, Switzerland). MYC-HA and FLAG-MYC plasmids were constructed by subcloning the corresponding human cDNA amplified by PCR into the pcDNA3 (Invitrogen) and pCMV-Tag2A (Stratagene) vectors, respectively. Transient transfection and reporter assays. 293T cells were transiently transfected by using the calcium phosphate precipitation method, and luciferase reporter assays were performed as previously described 45, 46 . Each transfection was done in duplicate, and luciferase activities were measured 48 h after transfection using the dual-luciferase reporter assay kit (Promega) according to the manufacturer's protocol.
Co-immunoprecipitation assay and western blot analysis. Nuclear cell extracts and whole cell lysates were prepared as previously described 47 . Proteins were analyzed by SDS-PAGE and subsequently by western blot using the following antibodies: anti-MYC (C33 and N262), anti-HDAC1 (N-19) and anti-NDR1 (STK38) (G15) (Santa Cruz Biotechnology); anti-BHLHB2/DEC1 (BL2928) (Bethyl); anti-MEF2B (ab33540) (Abcam); anti-STK38 (2G8-1F3) (Novus Biologicals); Flag M2 and anti-HA beads (Sigma); and hemagglutinin (Roche).
Quantitative chromatin immunoprecipitation (qChIP).
ChIP assays were performed as previously described 48, 49 . Antibodies used were anti-MYC (N-262, Santa Cruz), anti-BHLHB2/DEC1 (BL2928, Bethyl) and anti-HDAC1 (AB7028, Abcam). The immunoprecipitated chromatin fragments from two independent experiments were pooled together, and the amounts of sample immunoprecipitated shRNA samples was analyzed using two-sample t-test. For the GSEA analysis probe sets were sorted in decreasing order by the -log 10 of their t-test P values. Readers are referred to ref. 32 for details of the GSEA algorithm. In the GSEA plot, specific targets (MYC-or MINDy-signatures) are shown as vertical bars against the background of all B cell-expressed genes in the expression profiles, sorted from the most to the least differentially expressed following silencing of the candidate modulator. The curve represents a random walk where the value on the y axis is increased proportionally each time the gene on the x axis is one of the selected targets and decreased if it is part of the background. Weights are chosen proportionally to the statistical significance of the differential expression and to the relative number of targets in the signatures versus the background list, such that the curve starts and ends at y = 0. The statistical significance of the GSEA statistics (that is, the maximum height of the curve, called the enrichment score, ES) was determined by permutation test where the ranks of the probe sets were randomly shuffled 1,000 times. To determine the enrichment of MINDypredicted modulator-specific targets of MYC among the differentially expressed genes, probe sets that rank before the GSEA leading edge (the increasing phase of GSEA profile) were determined to be significantly differentially expressed, and the enrichment was calculated using the Fisher's exact test.
